top of page
Sharer, Dan,_edited.jpg

Dr. J. Daniel Sharer


Medical/Scientific Advisory Board Member

J. Daniel Sharer received his Ph.D. in Biochemistry and Molecular Biology from Robert Wood Johnson Medical School at Rutgers University in 1994 and completed postdoctoral training at the National Cancer Institute and the Departments of Biochemistry and Human Genetics at Emory University. He then joined the faculty at the University of Alabama at Birmingham (UAB) School of Medicine in 2005, where he established the first clinical diagnostic biochemical genetics laboratory in the state. Dr. Sharer is currently Professor and Director of the Biochemical Genetics and Metabolic Disease Laboratory in the UAB Department of Genetics. He is also the Director of the UAB Fellowship Training Program in Laboratory Medical Genetics and holds Adjunct Professor appointments in the UAB Civitan International Research Center, the UAB Center for Clinical and Translational Science, and the UAB Division of Nephrology Research and Training Center.


Dr. Sharer is certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Biochemical Genetics and is a current or former member of the American College of Medical Genetics (ACMG), the American Society of Human Genetics (ASHG), the Society for Inherited Metabolic Disorders (SIMD), and the American Society of Mass Spectrometry (ASMS). Dr. Sharer has served on numerous local, regional, and national councils and committees, including the Alabama Newborn Screening Advisory Committee, the Accreditation Council for Graduate Medical Education (ACGME) Medical Genetics and Genomics Review Committee, the ACMG Laboratory Quality Assurance Committee, and is currently President of the Southeast Regional Genetics Group (SERGG).


Dr. Sharer has received grant support and training awards from the National Institutes of Health, the ACMG Foundation, the UAB Health Service Foundation, SIMD/Ucyclyd, the National Cancer Institute, and the New Jersey Commission on Cancer Research.  He has served as a consultant to Atherotech Diagnostics and is an editor for Current Protocols in Human Genetics. He has published over 30 peer-reviewed manuscripts and abstracts, as well as three book chapters.

bottom of page